BioLineRx (BLRX) Change in Acquisitions & Divestments (2013 - 2025)

BioLineRx's Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at -$7.6 million for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to -$7.6 million; the TTM figure through Dec 2025 stood at -$36.6 million (down 39.07% YoY), while the FY2025 annual figure was -$36.6 million, down 39.07% from the prior year.
• Change in Acquisitions & Divestments was -$7.6 million for Q4 2025 at BioLineRx, down from -$4.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $16.7 million in Q1 2024 to a low of -$42.0 million in Q1 2021.
• Historically, Change in Acquisitions & Divestments has averaged -$12.2 million across 5 years, with a median of -$8.0 million in 2021.
• Biggest YoY gain for Change in Acquisitions & Divestments was 403.98% in 2024; the steepest drop was 7267.19% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at -$8.0 million in 2021, then changed by 0.0% to -$8.0 million in 2022, then slumped by 321.32% to -$33.7 million in 2023, then jumped by 82.82% to -$5.8 million in 2024, then plunged by 31.53% to -$7.6 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at -$7.6 million (Q4 2025), -$4.2 million (Q3 2025), and -$12.5 million (Q2 2025), per Business Quant data.